Earlier this year, trading shares of New York-based virtual content provider fuboTV (NYSE:FUBO) was a risky proposition. The price action of FUBO stock was like a roller-coaster ride, and not ideal for cautious investors. Source: Lori Butcher/ShutterStock.com However, moving into the last two months of 2021, the situation seemed much calmer … until the pain from
0 Comments
“Sell the news” seemed to be the market’s response to AMC Entertainment’s (NYSE:AMC) latest earnings report. After the close on Nov. 8, the movie theater chain reported higher-than-expected revenue ($763 million versus $708 million consensus) and a narrower-than-expected per-share loss (44 cents versus 53 cents consensus), for the quarter ending Sept. 30. Yet, it did not
0 Comments
Bionano Genomics (NASDAQ:BNGO) continues to take steps that will, in the long-term, tremendously boost its results and the share price. Consequently, I remain very bullish on BNGO stock. Source: Natali_ Mis/ShutterStock.com More specifically, the sales of Bionano’s Saphyr DNA mapping system are still accelerating, while a recent acquisition by the company should make the product
0 Comments
In this article TSLA WEN FUBO POSH A woman walks past a Westpac bank advertisement in central Sydney, Australia. Daniel Munoz | Reuters Check out the companies making headlines in midday trading. Poshmark — The online marketplace’s shares tumbled nearly 30% Wednesday after reporting quarterly results late Tuesday. Poshmark reported a loss of 9 cents
0 Comments
Rafael Henrique | LightRocket | Getty Images A McKinsey partner was arrested Wednesday after being criminally charged with insider trading ahead of Goldman Sachs‘ recent $2.2 billion acquisition of fintech lender GreenSky. Puneet Dikshit, a 40-year-old McKinsey partner, exploited information he gained about his client Goldman Sachs’ pending takeover to buy profitable call options in
0 Comments
There’s little reason to immediately invest in Virgin Galactic (NYSE:SPCE) stock following the delays of the company’s test flights.  Source: Tun Pichitanon / Shutterstock.com The postponements clearly lowered the company’s share price, which dropped 17% immediately following the news which was released on Oct. 14. No matter how you slice it, the market isn’t likely
0 Comments
Things appear to have gone from bad to worse for high-flying pharmaceutical company Moderna (NASDAQ:MRNA) stock, leaving shareholders reeling. Source: Ascannio / Shutterstock.com MRNA stock has cratered, dropping from $350 a share all the way down to $228. The steep fall came after the company reported disappointing quarterly results that shocked Wall Street and revised down
0 Comments
The semiconductor shortage has underscored just how important the little devices are. They’re in just about everything these days and the companies that make them are raking in the cash because of it. One such company is Advanced Micro Devices (NASDAQ:AMD). AMD stock has been a strong performer over the past few years as its
0 Comments